SELLAS Life Sciences Group (SLS) Shares Outstanding (Diluted Average): 2020-2024
Historic Shares Outstanding (Diluted Average) for SELLAS Life Sciences Group (SLS) over the last 5 years, with Sep 2024 value amounting to $68.3 million.
- SELLAS Life Sciences Group's Shares Outstanding (Diluted Average) rose 140.71% to $68.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $68.3 million, marking a year-over-year increase of 140.71%. This contributed to the annual value of $27.8 million for FY2023, which is 43.21% up from last year.
- Latest data reveals that SELLAS Life Sciences Group reported Shares Outstanding (Diluted Average) of $68.3 million as of Q3 2024, which was up 18.43% from $57.6 million recorded in Q2 2024.
- SELLAS Life Sciences Group's Shares Outstanding (Diluted Average)'s 5-year high stood at $68.3 million during Q3 2024, with a 5-year trough of $6.7 million in Q2 2020.
- Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $27.8 million (2023), whereas its average is $32.3 million.
- Data for SELLAS Life Sciences Group's Shares Outstanding (Diluted Average) shows a peak YoY surged of 140.71% (in 2024) over the last 5 years.
- Over the past 5 years, SELLAS Life Sciences Group's Shares Outstanding (Diluted Average) (Quarterly) stood at $8.0 million in 2020, then surged by 94.07% to $15.5 million in 2021, then grew by 25.29% to $19.4 million in 2022, then soared by 43.21% to $27.8 million in 2023, then skyrocketed by 140.71% to $68.3 million in 2024.
- Its Shares Outstanding (Diluted Average) was $68.3 million in Q3 2024, compared to $57.6 million in Q2 2024 and $44.8 million in Q1 2024.